help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Canas, X.
Right arrow Articles by Alemany, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Canas, X.
Right arrow Articles by Alemany, M.

Endocrinology, Vol 136, 3871-3876, Copyright © 1995 by Endocrine Society

ARTICLES

Rat insulin turnover in vivo

X Canas, JA Fernandez-Lopez, A Ardevol, C Adan, M Esteve, I Rafecas, X Remesar and M Alemany
Departament de Bioquimica i Fisiologia, Universitat de Barcelona, Spain.

Zucker lean and obese rats were injected under pentobarbital anesthesia with 125I-labeled insulin; at timed intervals from 30 to 120 sec, blood samples were extracted and used for the estimation of insulin levels by RIA. A group of rats from each series was maintained under a constant infusion of noradrenaline. For each insulin determination, a duplicate blood sample containing the same amount of insulin as that used in the RIA, but without the radioactive label, was used as a blank for insulin measurement. The radioactivity in these tubes was then used for the measurement of insulin label per ml blood. From plasma label decay curves and insulin concentrations, the insulin pool size, half-life, and rate of degradation were calculated. Obese rats had higher insulin levels (2.43 nM) and showed less effect of noradrenaline than their lean counterparts, in which insulin distribution volume shrank with noradrenaline treatment. The half-life of plasma insulin was similar in all groups (range, 226-314 sec). Pool size and overall degradation rates were higher in obese (198 femtokatals) than in lean rats (28 femtokatals). It is postulated that obese rats synthesize and cleave much more insulin than lean controls despite their higher circulating levels of insulin.


This article has been cited by other articles:


Home page
 J. Am. Coll. Nutr.Home page
M. E. Valera Mora, A. Scarfone, M. Calvani, A. V. Greco, and G. Mingrone
Insulin Clearance in Obesity
J. Am. Coll. Nutr., December 1, 2003; 22(6): 487 - 493.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R. Vila, C. Adan, I. Rafecas, J. A. Fernandez-Lopez, X. Remesar, and M. Alemany
Plasma Leptin Turnover Rates in Lean and Obese Zucker Rats
Endocrinology, November 1, 1998; 139(11): 4466 - 4469.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
W. C. Duckworth, R. G. Bennett, and F. G. Hamel
Insulin Degradation: Progress and Potential
Endocr. Rev., October 1, 1998; 19(5): 608 - 624.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society